RxDoctor Payments Data

Glenn Skow

Emergency Medicine · Vandalia, ILNPI 1396987053

Payments from drug & device makers

$632in general payments, 2019–2025

Across 58 payments — averaging $10.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$308
  • Organogenesis Inc.$130
  • Sanofi-aventis U.S. LLC$72
  • Esperion Therapeutics, Inc.$24
  • Johnson & Johnson$20
  • AbbVie$16
  • plus $63 from 5 others

What the payments were for

  • Food & beverage$632100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$632 in reported general payments places this provider in the 90th percentile of 2,434 emergency medicine providers in Illinois.

See all emergency medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$62,489
Medicare patients
439
Services billed
561

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ArexvyRsvpref3 Antigen/As01e/Pf35$10,778
EliquisApixaban12$6,904
ShingrixVaricella-Zoster Ge/As01b/Pf26$5,508
Boostrix TdapDiphth,pertuss(Acell),tet Vac22$1,500
Phenytoin Sodium Extended12$832
Ketorolac Tromethamine45$652
Cefdinir31$517
Ondansetron OdtOndansetron39$392
Levetiracetam12$355
Albuterol Sulfate HfaAlbuterol Sulfate11$296
FenofibrateFenofibrate Nanocrystallized11$287
Levothyroxine Sodium26$262
Glimepiride12$210
Fluticasone Propionate17$198
Montelukast Sodium27$195

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$12$6,90412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,434 emergency medicine providers in Illinois.

Other emergency medicine in Vandalia

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →